Azathioprine Tablets

designed to address chronic inflammation to target immune system activity.

Strengths: 25 · 50mg

Medicine details

Alternative names

Imuran

Therapeutic class

Immunosuppressant

Pharmacological class

Purine analogue

Known off-label uses

ulcerative colitis

Contraindications

hypersensitivity; severe infection; severe hepatic impairment

Precautions and warnings

monitor haematological counts regularly; avoid live vaccines

Minor side effects

nausea; loss of appetite

Moderate side effects

leukopenia; elevated liver enzymes

Serious side effects

bone marrow suppression — requires immediate medical attention

Dosage forms

Film-coated tablet

Administration route

Oral use

Patient summary

designed to address chronic inflammation to target immune system activity.

Prescription status

POM

Manufacturer

Aspen Pharma

Onset Time

2–4 weeks

Duration

constant

Storage instructions

Store below 25°C, protect from light.

Drug interactions

allopurinol; warfarin; ribavirin

Age restrictions

Adjust dose for paediatric use.

Pregnancy and breastfeeding

Pregnancy: avoid if possible. Breastfeeding: avoid, drug is excreted in milk.

Mechanism of action

Azathioprine acts as a purine antimetabolite, interfering with DNA and RNA synthesis, which inhibits the proliferation of cells involved in the immune response.

Azathioprine Tablets

designed to address chronic inflammation to target immune system activity.

Editorial Notes

  • Active ingredient(s): Azathioprine
  • Listed indication(s): Rheumatoid Arthritis, Crohn’s Disease, Transplant Rejection

Usually available as

  • 120 tablets - 25 mg1345-25-mg-16243
  • 90 tablets - 50 mg1345-50-mg-16236